Administrative Core
行政核心
基本信息
- 批准号:10708920
- 负责人:
- 金额:$ 37.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-22 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAccountabilityAdvocateAwarenessBiologicalCancer BiologyClinicClinicalClinical OncologyCombination immunotherapyCombined Modality TherapyCommunicationCommunitiesCutaneous MelanomaDataEducation and OutreachEducational MaterialsEducational process of instructingEngineeringEnvironmentEvaluationFacultyFeedbackFundingGoalsImmunotherapyInfrastructureInstitutionIntellectual PropertyLearningLogisticsMalignant NeoplasmsMentorsMonitorPatientsPersonsPilot ProjectsProcessProgram DescriptionProtocols documentationReagentResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResource SharingSTEM fieldScheduleScientistSelf-ExaminationSeriesSolid NeoplasmSpecimenStructureStudentsSystems BiologyTalentsThinkingTissuesTraining SupportTranslationsUnderrepresented MinorityUnderrepresented Populationsbiobankcollaborative environmentdesignflexibilityinhibitormeetingsmouse modelmultiple omicsoutreach programprogramsspatiotemporaltargeted treatmentteachertooltranslational goaltranslational potentialtumor
项目摘要
Administration and Coordination Core
Project Summary
The administrative and coordination core of the proposed U54 Center for Spatiotemporal Tumor Analytics for
Guiding Sequential Targeted Inhibitor : Immunotherapy Combinations (ST-Analytics is designed to
promote and support the integrated research efforts of scientists from the ISB, Yale, and UCLA, as well as our
Outreach program, our Pilot Projects and Cross-Consortium Projects. The scientific programs of ST-Analytics
are designed to resolve how to best harness immunotherapy/targeted therapy sequential combinations for the
treatment of solid tumors in the clinic, starting with a focus on metastatic cutaneous melanoma. This requires
bringing together a cross-disciplinary mix of clinical, biological, physical, engineering, and computational
scientists, as well as state-of-the-art, multiomic profiling tools, syngeneic mouse models, and a rich bio-repository
of highly relevant patient tissues. Meeting the ST-Analytics scientific goals requires a responsive administrative
structure that (i) promotes and enables effective communication and resource sharing between the ST-Analytics
researchers and the broader Cancer Systems Biology Consortium (CSBC), (ii) establishes a highly interactive
environment wherein ST-Analytics researchers can be good students and teachers of each other, (iii) promotes
achieving the program specific aims in a timely manner, (iv) intervenes as early as possible when scientific and
logistic conflicts arise, (v) promotes diversity in our scientific workforce through various mechanisms, including
but not limited to seed project funding, outreach programs, and raising awareness of these critical issues during
our remote and in-person meetings, and (vi) monitoring the scientific integrity and robustness of scientific
designs. The ST-Analytics administrative CORE should facilitate the free flow of data, new ideas, experimental
protocols, customized reagents, and biospecimens between the institutions. It should establish working
relationships with other funded centers. It should facilitate clinical or commercial translation and educational
outreach. It should encourage flexible thinking in anticipation of new opportunities or unexpected roadblocks.
Finally, it should facilitate a healthy environment of self-evaluation.
管理与协调核心
项目摘要
拟议U54时空肿瘤分析中心的行政和协调核心
指导顺序靶向抑制剂:免疫疗法组合(ST-Analytics设计用于
促进和支持来自ISB,耶鲁大学和加州大学洛杉矶分校的科学家的综合研究工作,以及我们
外展计划,我们的试点项目和跨第一个项目。 St-Analytics的科学计划
旨在解决如何最好地利用免疫疗法/靶向治疗的顺序组合
诊所中实体瘤的治疗,首先关注转移性皮肤黑色素瘤。这需要
将临床,生物,物理,工程和计算的跨学科组合汇总在一起
科学家以及最先进的多构谱工具,合成鼠标模型和丰富的生物重复性
高度相关的患者组织。实现ST-Analytics科学目标需要响应迅速的行政
(i)促进和启用ST分析之间有效的沟通和资源共享的结构
研究人员和更广泛的癌症系统生物联盟(CSBC),(ii)建立了高度互动的
ST-Analytics研究人员可以成为好学生和老师的环境,(iii)促进
达到该计划的特定目的是及时的,(iv)在科学和
出现后勤冲突,(v)通过包括各种机制,包括
但不仅限于种子项目资金,外展计划,并提高了对这些关键问题的认识
我们的遥远和面对面的会议,以及(vi)监视科学的科学完整性和鲁棒性
设计。 St-Analytics行政核心应促进数据的自由流,新想法,实验性
机构之间的协议,定制试剂和生物测量。它应该建立工作
与其他资助中心的关系。它应该促进临床或商业翻译和教育
外展。它应该鼓励灵活的思考,以期待新的机会或意外的障碍。
最后,它应该促进自我评估的健康环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James R. Heath其他文献
Protein Catalyzed Capture (PCC) Agents for Antigen Targeting.
用于抗原靶向的蛋白质催化捕获 (PCC) 试剂。
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
M. Idso;B. Lai;Heather D Agnew;James R. Heath - 通讯作者:
James R. Heath
Planar Patch-Clamp Electrodes for Single Cell and Neural Network Studies
- DOI:
10.1016/j.bpj.2009.12.3287 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
John M. Nagarah;Daniel A. Wagenaar;James R. Heath - 通讯作者:
James R. Heath
Stereochemical engineering of a peptide macrocycle allosteric inhibitor of phospho-Akt2 controls cell penetration by fine-tuning macrocycle-cell membrane interactions
磷酸 Akt2 肽大环变构抑制剂的立体化学工程通过微调大环 - 细胞膜相互作用来控制细胞渗透
- DOI:
10.26434/chemrxiv-2021-kldh7 - 发表时间:
2021 - 期刊:
- 影响因子:5.9
- 作者:
Arundhati Nag;A. Mafi;Samir R Das;Mary Beth Yu;Belen Alvarez;W. Goddard;James R. Heath - 通讯作者:
James R. Heath
Calcium and Photoentrainment in Chick Pineal Cells Revisited: Effects of Caffeine, Thapsigargin, EGTA, and Light on the Melatonin Rhythm
重新审视小鸡松果体细胞中的钙和光夹带:咖啡因、毒胡萝卜素、EGTA 和光对褪黑激素节律的影响
- DOI:
10.1046/j.1471-4159.1995.65031332.x - 发表时间:
1995 - 期刊:
- 影响因子:4.7
- 作者:
M. Zatz;James R. Heath - 通讯作者:
James R. Heath
Evaluation of biodegradable ampicillin anhydrate microcapsules for local treatment of experimental staphylococcal osteomyelitis.
可生物降解的无水氨苄青霉素微胶囊局部治疗实验性葡萄球菌骨髓炎的评价。
- DOI:
- 发表时间:
1991 - 期刊:
- 影响因子:4.2
- 作者:
E. Jacob;J. Setterstrom;D. E. Bach;James R. Heath;L. M. Mcniesh;G. Cierny - 通讯作者:
G. Cierny
James R. Heath的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James R. Heath', 18)}}的其他基金
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
用于指导序贯靶向抑制剂的时空肿瘤分析:免疫治疗组合(ST-Analytics)
- 批准号:
10708901 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别:
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
项目 1:基于时间的时空癌症免疫图预测免疫治疗靶向治疗顺序组合
- 批准号:
10907268 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别:
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
用于指导序贯靶向抑制剂的时空肿瘤分析:免疫治疗组合(ST-Analytics)
- 批准号:
10526101 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别:
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
项目 1:基于时间的时空癌症免疫图预测免疫治疗靶向治疗顺序组合
- 批准号:
10526103 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别:
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
项目 1:基于时间的时空癌症免疫图预测免疫治疗靶向治疗顺序组合
- 批准号:
10708924 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别:
Data-driven Patient-Specific Agent Based Models of Metastatic Melanoma for Immunotherapy Response Prediction
用于免疫治疗反应预测的数据驱动的基于患者特异性药物的转移性黑色素瘤模型
- 批准号:
10831325 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别:
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
用于新抗原特异性 T 细胞捕获和表征的纳米和生物分子工程技术
- 批准号:
10297588 - 财政年份:2021
- 资助金额:
$ 37.85万 - 项目类别:
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
用于新抗原特异性 T 细胞捕获和表征的纳米和生物分子工程技术
- 批准号:
10489832 - 财政年份:2021
- 资助金额:
$ 37.85万 - 项目类别:
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
用于新抗原特异性 T 细胞捕获和表征的纳米和生物分子工程技术
- 批准号:
10673935 - 财政年份:2021
- 资助金额:
$ 37.85万 - 项目类别:
相似国自然基金
问责制度何以影响地方政府绩效——目标责任制情境下的“问责悖论”研究
- 批准号:71103140
- 批准年份:2011
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Center for Dissemination and Implementation At Stanford (C-DIAS): Administrative Core
斯坦福大学传播与实施中心 (C-DIAS):行政核心
- 批准号:
10668468 - 财政年份:2022
- 资助金额:
$ 37.85万 - 项目类别: